Status:
UNKNOWN
Residual Platelet Reactivity in Patients on Antiplatelet Therapy After Carotid Angioplasty With Stenting
Lead Sponsor:
Azienda Ospedaliera di Perugia
Collaborating Sponsors:
University Of Perugia
Conditions:
Carotid Artery Disease
Eligibility:
All Genders
18-80 years
Brief Summary
A carotid stenosis is treated with invasive procedures of revascularization when the lumen is reduced by more than 70% or when the lumen is reduced by more than 50% in patients who have had symptoms a...
Detailed Description
STUDY DESIGN The study will enroll 110 patients undergoing stenting for critical carotid stenosis, either symptomatic (previous events of cerebral ischemia) or asymptomatic, undergoing CAS. All patie...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Informed written consent
- No contraindications to dual-antiplatelet treatment
- Exclusion criteria
- Age \< 18 or \> 80 years old
- Use of oral anticoagulants
- Use of dipyridamole, cilostazol, NSAIDs
- Myeloproliferative syndrome or paraproteinemia
- Liver or kidney failure
- Thrombocytopathies
- Platelets count \< 100000 or \> 450000/µl
- Haemoglobin \< 8g/dl
Exclusion
Key Trial Info
Start Date :
August 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2016
Estimated Enrollment :
272 Patients enrolled
Trial Details
Trial ID
NCT01449617
Start Date
August 1 2010
End Date
March 1 2016
Last Update
July 17 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda Ospedaliera di Perugia
Perugia, Italy, Italy, 06123